125 related articles for article (PubMed ID: 22433278)
1. Aciclovir for dual infection with HIV and HSV.
Verjans GM; Boucher CA
Lancet Infect Dis; 2012 Jun; 12(6):424-5. PubMed ID: 22433278
[No Abstract] [Full Text] [Related]
2. Effect of daily aciclovir on HIV disease progression in individuals in Rakai, Uganda, co-infected with HIV-1 and herpes simplex virus type 2: a randomised, double-blind placebo-controlled trial.
Reynolds SJ; Makumbi F; Newell K; Kiwanuka N; Ssebbowa P; Mondo G; Boaz I; Wawer MJ; Gray RH; Serwadda D; Quinn TC
Lancet Infect Dis; 2012 Jun; 12(6):441-8. PubMed ID: 22433279
[TBL] [Abstract][Full Text] [Related]
3. HSV therapy and HIV-1 reduction.
Martinez V; Caumes E
N Engl J Med; 2007 May; 356(22):2323; author reply 2324. PubMed ID: 17538093
[No Abstract] [Full Text] [Related]
4. Treating HIV infection with drugs for HSV-2 infection?
Buvé A; Lynen L
Lancet; 2010 Mar; 375(9717):782-4. PubMed ID: 20153889
[No Abstract] [Full Text] [Related]
5. A missed point in deciphering the viral synergy between herpes simplex virus and HIV.
Lisco A; Vanpouille C; Margolis L
Lancet Infect Dis; 2009 Sep; 9(9):522-3. PubMed ID: 19695487
[No Abstract] [Full Text] [Related]
6. Treatment of HIV infection with drugs for HSV-2 infection.
Huttner A; Calmy A
Lancet; 2010 Jul; 376(9735):88; author reply 88. PubMed ID: 20621229
[No Abstract] [Full Text] [Related]
7. The cost-effectiveness of herpes simplex virus-2 suppressive therapy with daily aciclovir for delaying HIV disease progression among HIV-1-infected women in South Africa.
Vickerman P; Devine A; Foss AM; Delany-Moretlwe S; Mayaud P; Meyer-Rath G
Sex Transm Dis; 2011 May; 38(5):401-9. PubMed ID: 21317689
[TBL] [Abstract][Full Text] [Related]
8. [Herpes simplex virus types 1 and 2 (HSV-1 and HSV-2)].
Thouvenot D; Najioullah F
Rev Prat; 1999 Dec; 49(20):2203-7. PubMed ID: 10731803
[TBL] [Abstract][Full Text] [Related]
9. Effect of aciclovir on HIV-1 acquisition in HSV-2-positive patients.
Hudson CP
Lancet; 2008 Oct; 372(9646):1298; author reply 1298-9. PubMed ID: 18929897
[No Abstract] [Full Text] [Related]
10. Successful treatment of aciclovir and foscarnet resistant Herpes simplex virus lesions with topical imiquimod in patients infected with human immunodeficiency virus type 1.
Lascaux AS; Caumes E; Deback C; Melica G; Challine D; Agut H; Lévy Y
J Med Virol; 2012 Feb; 84(2):194-7. PubMed ID: 22170537
[TBL] [Abstract][Full Text] [Related]
11. Hypertrophic genital herpes simplex due to HSV 2 sensitive to maximum dose of oral aciclovir.
Folch H; Jahr C; Giacaman P; Zuñiga P; Del Pino M
Clin Exp Dermatol; 2023 Jan; 48(1):43-44. PubMed ID: 36631433
[No Abstract] [Full Text] [Related]
12. HSV therapy and HIV-1 reduction.
Eisenhut M
N Engl J Med; 2007 May; 356(22):2323-4; author reply 2324. PubMed ID: 17542070
[No Abstract] [Full Text] [Related]
13. Herpes simplex virus (HSV)-suppressive therapy decreases plasma and genital HIV-1 levels in HSV-2/HIV-1 coinfected women: a randomized, placebo-controlled, cross-over trial.
Baeten JM; Strick LB; Lucchetti A; Whittington WL; Sanchez J; Coombs RW; Magaret A; Wald A; Corey L; Celum C
J Infect Dis; 2008 Dec; 198(12):1804-8. PubMed ID: 18928378
[TBL] [Abstract][Full Text] [Related]
14. Management of neonatal herpes simplex virus infection.
Kesson AM
Paediatr Drugs; 2001; 3(2):81-90. PubMed ID: 11269641
[TBL] [Abstract][Full Text] [Related]
15. Use of pritelivir in refractory aciclovir-resistant herpes simplex virus type 2.
Cannon L; Tholouli E; Ward C; Farooq H; Kingston M
Int J STD AIDS; 2021 Sep; 32(10):978-980. PubMed ID: 33947276
[TBL] [Abstract][Full Text] [Related]
16. Clinical presentation of herpes simplex virus infection mimicking neoplasia on the face of persons living with HIV.
Edwards RJ; Dolly N; Musa D; Edwards J; Boyce G
Int J STD AIDS; 2022 Feb; 33(2):212-214. PubMed ID: 34726092
[TBL] [Abstract][Full Text] [Related]
17. Herpes simplex virus (HSV) suppression with valacyclovir reduces rectal and blood plasma HIV-1 levels in HIV-1/HSV-2-seropositive men: a randomized, double-blind, placebo-controlled crossover trial.
Zuckerman RA; Lucchetti A; Whittington WL; Sanchez J; Coombs RW; Zuñiga R; Magaret AS; Wald A; Corey L; Celum C
J Infect Dis; 2007 Nov; 196(10):1500-8. PubMed ID: 18008230
[TBL] [Abstract][Full Text] [Related]
18. Changes in plasma human immunodeficiency virus type 1 RNA associated with herpes simplex virus reactivation and suppression.
Schacker T; Zeh J; Hu H; Shaughnessy M; Corey L
J Infect Dis; 2002 Dec; 186(12):1718-25. PubMed ID: 12447756
[TBL] [Abstract][Full Text] [Related]
19. Recurrent aciclovir-resistant herpes simplex in a child with Wiskott-Aldrich syndrome.
Saijo M; Suzutani T; Murono K; Hirano Y; Itoh K
Br J Dermatol; 1998 Aug; 139(2):311-4. PubMed ID: 9767251
[TBL] [Abstract][Full Text] [Related]
20. Long-term follow-up of HIV-infected patients once diagnosed with acyclovir-resistant herpes simplex virus infection.
Seang S; Boutolleau D; Burrel S; Regnier S; Epelboin L; Voujon D; Valantin MA; Katlama C; Agut H; Caumes E
Int J STD AIDS; 2014 Aug; 25(9):676-82. PubMed ID: 24535691
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
